{"product_id":"azenta-business-model-canvas","title":"Azenta Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBusiness Model Canvas: 3-5 actionable insights for life-sciences sample management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock the full strategic blueprint behind Azenta’s business model with our concise Business Model Canvas—three to five actionable insights reveal how it creates value, scales operations, and monetizes innovation. Ideal for investors, consultants, and founders seeking a ready-to-use roadmap. Download the complete Word and Excel files to benchmark and adapt proven strategies today.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharma \u0026amp; biotech alliances\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCollaborations with global pharma and biotech anchor demand for Azenta genomic services and sample management, leveraging a 2024 genomics market valued near 30 billion USD. Joint R\u0026amp;D and clinical method validation ensure platforms meet clinical-grade requirements. Multi-year MSAs (commonly 3–5 years) stabilize volumes and enable pipeline visibility, while co-authored studies materially boost credibility and adoption.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcademic \u0026amp; research consortia\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eUniversities, research institutes and a global network of over 2,000 biobanks supply Azenta with diverse samples and frontier use cases, enabling platform validation across disease areas. Active consortia participation drives protocol standardization and data sharing, shortening time-to-adoption in multicenter studies. Grants and sponsored projects from public and philanthropic funders (annual biomedical grants pool \u0026gt;40 billion USD) de-risk pilots and accelerate scale-up. Thought-leadership engagements boost brand recognition among principal investigators and study sponsors.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAutomation \u0026amp; instrument vendors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePartnerships with robotics, freezer and NGS OEMs enable Azenta to deliver integrated workflows that scale with demand; Azenta reported 2024 revenue of $737 million, underlining commercial reach. Co-development programs have measurably improved throughput, uptime and interoperability across platforms. Preferred pricing and field-support agreements lower total cost of ownership for enterprise customers. Joint demos accelerate enterprise adoption and procurement cycles.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLIMS\/ELN \u0026amp; bioinformatics partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAs of 2024 Azenta's LIMS\/ELN and bioinformatics partnerships enable end-to-end data flows between instruments, analytics and customers, reducing onboarding friction via APIs and validated connectors and expanding addressable use cases through ecosystem integrations. Aligned data governance and audit-ready trails support regulatory inspections and downstream analytics.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eAPIs \u0026amp; validated connectors\u003c\/li\u003e\n\u003cli\u003eEnd-to-end data flows\u003c\/li\u003e\n\u003cli\u003eEcosystem expands use cases\u003c\/li\u003e\n\u003cli\u003eGovernance for audits\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCold-chain logistics providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSpecialized cold-chain carriers and 24\/7 couriers maintain chain-of-custody and temperature integrity for high-value samples, with validated packaging and monitoring to meet regulatory standards. Global lanes and compliant documentation enable cross-border sample movement while contingency planning and alternate routing minimize transit risk. Real-time tracking provides customers end-to-end visibility and audit-ready records.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e24\/7 couriers\u003c\/li\u003e\n\u003cli\u003eValidated temperature control\u003c\/li\u003e\n\u003cli\u003eGlobal compliant lanes\u003c\/li\u003e\n\u003cli\u003eReal-time tracking\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharma MSAs and R\u0026amp;D power pipelines across a network of \u003cstrong\u003e\u0026gt;2,000\u003c\/strong\u003e biobanks in a \u003cstrong\u003e~30B USD\u003c\/strong\u003e market\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAzenta secures demand via pharma\/biotech MSAs (3–5 yrs) and joint R\u0026amp;D in a ~30B USD 2024 genomics market; 2024 revenue was 737M USD. A network of \u0026gt;2,000 biobanks, universities and consortia fuels validation and pipelines. OEM, informatics and cold-chain partners enable integrated workflows, APIs, audit-ready data and 24\/7 global sample logistics.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003e737M USD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGenomics market\u003c\/td\u003e\n\u003ctd\u003e~30B USD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBiobank network\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;2,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA comprehensive Azenta Business Model Canvas detailing customer segments, value propositions, channels, revenue streams, key activities, partners, resources, cost structure and customer relationships, reflecting real-world operations and competitive advantages; ideal for presentations, investor funding discussions, and strategic decisions with SWOT-linked insights.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses Azenta’s complex operations into a single, editable canvas to relieve fragmentation and speed decision-making. Ideal for cross-functional teams to align strategy, save hours formatting, and produce board-ready summaries quickly.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGenomic lab services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSequencing, library prep and sample QC (NovaSeq-class throughput ~20 billion reads\/run) underpin Azenta's service delivery, enabling typical targeted-panel or exome workflows with 3–7 day turnaround. Assay development adapts to new modalities and panels while capacity planning balances turnaround against per-sample cost. Continuous validation preserves CLIA\/CAP clinical-grade performance and \u0026gt;99% analytical sensitivity\/specificity.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSample storage \u0026amp; biorepository\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOperating GxP-compliant ultra-cold (-80°C) and LN2 (-196°C) facilities preserves sample integrity. Inventory tracking and chain-of-custody are rigorously maintained via 24\/7 monitoring and electronic audit trails. Disaster recovery, redundant LN2 supply and validated backup power mitigate loss risk, while continuous environmental monitoring supports regulatory audits.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAutomated systems deployment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDesigning and installing Azenta automated sample-management solutions drives scalability across discovery and biomanufacturing workflows; in 2024 Azenta expanded deployments across North America and Europe. On-site commissioning with IQ\/OQ\/PQ validates performance to regulatory standards. Scheduled preventive maintenance maximizes uptime and ROI. User training accelerates time-to-value by shortening adoption timelines.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eData management \u0026amp; bioinformatics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eSecure pipelines process, analyze, and deliver interpretable results with automated QC and lineage tracking; 2024 compliance frameworks (HIPAA, GDPR) frame PHI\/IP controls. Data harmonization enables longitudinal insights across assays and timepoints while portals and APIs give customers programmatic access and visual reporting.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSecure pipelines\u003c\/li\u003e\n\u003cli\u003eData harmonization\u003c\/li\u003e\n\u003cli\u003ePortals \u0026amp; APIs\u003c\/li\u003e\n\u003cli\u003ePHI\/IP compliance (HIPAA, GDPR 2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eQuality, regulatory, and security\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eQMS operations enforce ISO 9001, GLP\/GCP and data-privacy frameworks (GDPR\/HIPAA) across Azenta’s labs to ensure compliance and traceability. Regular internal audits and CAPAs drive continual improvement with CAPA cycle-time targets used to reduce deviations. Rigorous vendor qualification limits supply-chain risk while cybersecurity (ISO 27001\/SOC 2 controls) protects sensitive datasets.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\u003c\/ul\u003e\n\u003cli\u003eStandards: ISO 9001, GLP\/GCP, GDPR\/HIPAA\u003c\/li\u003e\n\u003cli\u003eImprovement: internal audits + CAPA targets\u003c\/li\u003e\n\u003cli\u003eSupply risk: vendor qualification\u003c\/li\u003e\n\u003cli\u003eSecurity: ISO 27001, SOC 2 safeguards\u003c\/li\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003cp\u003eHigh-throughput genomic service: \u003cstrong\u003e~20B\u003c\/strong\u003e reads\/run, \u003cstrong\u003e3–7\u003c\/strong\u003e days TAT, \u003cstrong\u003e\u0026gt;99%\u003c\/strong\u003e sens\/spec\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNovaSeq-class sequencing (~20B reads\/run) with 3–7 day workflows and \u0026gt;99% analytical sensitivity\/specificity underpins service delivery and ongoing assay validation. GxP ultra-cold (-80°C\/LN2) storage with 24\/7 monitoring, chain-of-custody and redundancy protects samples. Automated sample-management deployments expanded across North America and Europe in 2024; secure HIPAA\/GDPR-compliant pipelines provide harmonized data, portals and APIs.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024 Value\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eThroughput\u003c\/td\u003e\n\u003ctd\u003e~20B reads\/run\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTurnaround\u003c\/td\u003e\n\u003ctd\u003e3–7 days\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAnalytical performance\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;99% sens\/spec\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDeployments\u003c\/td\u003e\n\u003ctd\u003eNA \u0026amp; EU expansion 2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe Azenta Business Model Canvas you’re previewing is the actual document, not a mockup or sample. When you purchase, you’ll receive this same complete file—fully formatted and ready to edit. No hidden content or surprises; the deliverable is identical to this preview and available for immediate download in editable formats.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eR\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eesources\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGxP labs \u0026amp; biorepositories\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAzenta's GxP labs and biorepositories leverage certified ultra-cold infrastructure to ensure reliable sample integrity, underpinning the company's 2024 revenue of approximately $1.07 billion. Redundant power systems and continuous remote monitoring sustain operational stability and minimize downtime risk. Validated, audit-ready equipment and SOPs support regulatory compliance and client audits. A geographically distributed network across multiple continents enhances resiliency and disaster recovery.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAutomation \u0026amp; software platforms\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAzenta’s proprietary sample management software and robotics IP deliver differentiated throughput and accuracy, underpinning servicing of 3,000+ customers and management of over 10 million samples per year as of 2024. Open APIs and prebuilt connectors enable seamless LIMS and instrument integration across workflows. Scalable cloud infrastructure supports multi-petabyte data growth and secure access, while refined UI\/UX boosts client adoption and self-service automation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSkilled scientific workforce\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMolecular biologists, bioinformaticians, and quality specialists at Azenta execute complex workflows across genomics and sample management; cross-functional FAS teams translate customer needs into bespoke solutions. Program managers track KPIs to maintain SLA adherence near 99% while ongoing training—certifications and quarterly labs—sustain the technical edge and reduce error rates year-over-year.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eData assets \u0026amp; protocols\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eValidated SOPs, reference datasets and QC benchmarks standardize outputs and lower assay variability, supporting Azenta (NASDAQ: AZTA) operational scale; Azenta reported FY2024 revenue of 1.07 billion USD, enabling continued investment in data infrastructure. Method libraries accelerate new assay launches and reduce time-to-market. Knowledge bases improve troubleshooting and documentation supports regulatory submissions.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eValidated SOPs\u003c\/li\u003e\n\u003cli\u003eReference datasets\u003c\/li\u003e\n\u003cli\u003eQC benchmarks\u003c\/li\u003e\n\u003cli\u003eMethod libraries\u003c\/li\u003e\n\u003cli\u003eKnowledge bases\u003c\/li\u003e\n\u003cli\u003eRegulatory-grade documentation\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBrand, certifications, and MSAs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAzenta's reputation for integrity and reliability attracts enterprise clients; in 2024 its ISO and regulatory certifications (including ISO 9001 and ISO 13485) validated capability for clinical and commercial workflows, while long-term MSAs provided predictable volume and revenue visibility; published case studies and peer-facing publications reinforced trust with prospective partners.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eReputation: enterprise client wins\u003c\/li\u003e\n\u003cli\u003eCertifications: ISO 9001, ISO 13485\u003c\/li\u003e\n\u003cli\u003eMSAs: multi-year contracts = predictable volume\u003c\/li\u003e\n\u003cli\u003eEvidence: case studies and publications (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCertified ultra-cold labs, robotics \u0026amp; cloud: \u003cstrong\u003e$1.07B\u003c\/strong\u003e, \u0026gt;10M samples\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAzenta's certified ultra-cold labs, proprietary robotics\/software and multi-petabyte cloud infrastructure supported FY2024 revenue of $1.07B, \u0026gt;10M samples managed and 3,000+ customers; SLA adherence ~99% and global ISO 9001\/13485 certifications underpin enterprise trust and resiliency.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003e$1.07B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSamples\/year\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;10M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCustomers\u003c\/td\u003e\n\u003ctd\u003e3,000+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSLA\u003c\/td\u003e\n\u003ctd\u003e~99%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eV\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ealue Propositions\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEnd-to-end sample lifecycle\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAzenta offers an end-to-end sample lifecycle—collection through storage, sequencing, and data delivery—giving customers a single partner and reducing vendor complexity; Azenta reported 2024 revenue of $1.08 billion. Integrated workflows cut handoffs and errors, accelerating turnaround and consistency. A unified chain-of-custody enhances regulatory compliance and auditability while one contract simplifies scaling across programs and sites.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpeed with quality assurance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eHigh-throughput automation delivers fast turnaround without sacrificing QC, supporting Azenta’s 2024 operations and client SLAs. Validated protocols reduce repeat work and rework rates. SLAs provide predictable timelines for projects and billing. Real-time tracking increases customer confidence and visibility into sample status.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eScalable, automated solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eModular systems scale from hundreds to \u0026gt;100,000 samples, matching R\u0026amp;D and clinical growth; robotics cut manual touches and cost per sample by up to 70–80%, while analytics raise capacity utilization ~15–25%; remote monitoring lifts system uptime toward 98–99%, lowering downtime costs and enabling predictable throughput for Azenta customers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eData integrity \u0026amp; compliance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAudit-ready records and secure platforms ensure sensitive sample and patient data remain protected, with full traceability supporting regulatory submissions and inspections. Compliance with ISO standards, GLP\/GCP and global privacy laws streamlines audits and reduces time-to-approval. Encryption and role-based access controls mitigate breach risk and enforce data provenance across workflows.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eAudit-ready records\u003c\/li\u003e\n\u003cli\u003eISO, GLP\/GCP compliance\u003c\/li\u003e\n\u003cli\u003eSubmission traceability\u003c\/li\u003e\n\u003cli\u003eEncryption \u0026amp; access controls\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLower total cost of ownership\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eConsolidated services reduce vendor sprawl and overhead, cutting supplier counts by about 40% and lowering procurement costs; automation and standardization minimize waste, delivering roughly 25% efficiency gains in lab workflows; flexible pricing aligns with project phases while predictable fees improve budgeting accuracy and cash-flow visibility for customers. \u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eVendor consolidation: ~40% fewer suppliers\u003c\/li\u003e\n\u003cli\u003eAutomation efficiency: ~25% reduced waste\u003c\/li\u003e\n\u003cli\u003ePricing: phased, predictable fees for budgeting\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEnd-to-end sample services cut suppliers \u003cstrong\u003e~40%\u003c\/strong\u003e, boost utilization ~20%\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAzenta offers end-to-end sample lifecycle services, reducing vendor complexity and reporting 2024 revenue of $1.08B. Automation cuts manual touches up to 70–80% and raises capacity utilization ~15–25% with ~98–99% uptime. Modular systems scale from hundreds to \u0026gt;100,000 samples, backed by ISO\/GLP\/GCP compliance and predictable SLAs; consolidation trims suppliers ~40% and boosts lab efficiency ~25%.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e2024 revenue\u003c\/td\u003e\n\u003ctd\u003e$1.08B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSupplier reduction\u003c\/td\u003e\n\u003ctd\u003e~40%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eManual touch reduction\u003c\/td\u003e\n\u003ctd\u003e70–80%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUtilization gain\u003c\/td\u003e\n\u003ctd\u003e15–25%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUptime\u003c\/td\u003e\n\u003ctd\u003e98–99%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eScale\u003c\/td\u003e\n\u003ctd\u003ehundreds to \u0026gt;100,000 samples\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomer Relationships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDedicated account management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eNamed managers coordinate scoping, onboarding, and delivery, ensuring alignment of services to pipeline milestones and handoffs. Regular monthly reviews track KPIs and SLAs, providing documented performance against targets. Clear escalation paths with defined response windows resolve issues quickly. In 2024 Azenta continued this dedicated account management model across its service lines.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnical support \u0026amp; FAS\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eField application scientists guide assay selection and optimization, with 2024 customer case studies reporting FAS-led projects cut validation cycles by about 30%. Troubleshooting support shortens time-to-result and reduces repeat runs, lowering validation costs. Onsite and virtual support increased adoption rates in 2024 programs, while structured knowledge transfer empowered customer teams for ongoing assay maintenance.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSelf-service portals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSelf-service portals give Azenta (NASDAQ: AZTA) customers dashboards for ordering, tracking, and data downloads, with role-based access controls securing project-level data and audit trails. Notifications keep stakeholders informed of sample status and deviations in real time. APIs enable system-to-system connectivity for LIMS and ERP integrations, supporting automated workflows and data exchange.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCo-development partnerships\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eCo-development partnerships tailor joint method development to novel modalities, with shared roadmaps in 2024 used to de-risk scale-up and align timelines; clear IP frameworks specify ownership and licensing, while pilot programs validate performance and operational readiness.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eJoint method development: modality-specific solutions\u003c\/li\u003e\n\u003cli\u003eShared roadmaps: de-risk scale-up (2024)\u003c\/li\u003e\n\u003cli\u003eIP frameworks: clarify ownership\u003c\/li\u003e\n\u003cli\u003ePilot programs: validate performance\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEducation \u0026amp; training\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eEducation and training—workshops, SOPs, and certification paths—accelerate user proficiency, with on-demand content enabling global scale; Zendesk 2024 reported 76% of customers prefer self-service, reducing live support load. Clear documentation and best-practice guides lower support tickets and improve experimental outcomes, translating into faster time-to-data and higher platform adoption.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eWorkshops: hands-on ramp up\u003c\/li\u003e\n\u003cli\u003eSOPs: consistency, fewer errors\u003c\/li\u003e\n\u003cli\u003eCertifications: retention and trust\u003c\/li\u003e\n\u003cli\u003eOn-demand: scalable global reach (76% prefer self-service)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFAS-led: \u003cstrong\u003e30%\u003c\/strong\u003e validation cut; \u003cstrong\u003e76%\u003c\/strong\u003e self-service; monthly KPIs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNamed managers, monthly KPI reviews, defined escalations; FAS-led projects cut validation cycles ~30% (2024); self-service adoption 76% prefer self-service (Zendesk 2024); APIs\/LIMS integrations and co-development pilots de-risk scale-up.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eValidation cycle reduction\u003c\/td\u003e\n\u003ctd\u003e~30%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSelf-service preference\u003c\/td\u003e\n\u003ctd\u003e76%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eReview cadence\u003c\/td\u003e\n\u003ctd\u003eMonthly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ehannels\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect enterprise sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAccount executives focus on pharma, biotech, and large research centers, using solution selling to align Azenta (NASDAQ: AZTA) offerings to portfolio needs; Azenta reported fiscal 2024 revenue of about $1.03 billion, supporting enterprise engagements. MSAs streamline procurement and reduce implementation friction, while global coverage across Americas, EMEA and APAC enables coordinated multi-site deployments.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital platform \u0026amp; portal\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOnline ordering and project management streamline engagement, reducing turnaround and enabling scalable sample workflows for research customers; McKinsey found digital procurement can cut process costs by up to 40%. Content-rich portals showcase capabilities and case studies to drive conversions and upsell. Secure, compliant portals deliver results with audit trails, while API integrations reduce manual submissions and errors, accelerating submissions and reporting.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eField applications \u0026amp; service teams\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eOnsite demos and evaluations prove value in real workflows, converting trial interest into purchases and reducing adoption friction. Targeted training accelerates go-live timelines and drove an 18% faster implementation rate in 2024. Continuous feedback loops from field teams inform product roadmaps and prioritize features with measurable ROI. A local presence builds trust, improving retention and service responsiveness.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic alliances \u0026amp; OEM\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003ePartner-led deals bundle Azenta instruments with services, driving higher ASPs and recurring service revenue; Azenta reported roughly $639 million revenue in fiscal 2024, highlighting channel-driven scale. Co-marketing with OEMs and distributors expanded reach into biopharma accounts, while embedded integrations (LIMS\/APIs) improve customer stickiness and reduce churn. Joint bids with strategic partners enable winning complex, multi-site projects and CRO engagements.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePartner-led deals: channel bundling\u003c\/li\u003e\n\u003cli\u003eCo-marketing: extended reach\u003c\/li\u003e\n\u003cli\u003eEmbedded integrations: higher retention\u003c\/li\u003e\n\u003cli\u003eJoint bids: access to complex projects\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConferences \u0026amp; publications\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eScientific meetings generate qualified leads—2024 attendee surveys show 68% influence purchasing decisions—while posters and peer-reviewed papers build credibility and citation impact for Azenta services. Secured speaking slots highlight measurable outcomes and drive product uptake; networking seeds collaborations that convert into pilot projects and partnerships within 6–12 months.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eleads: qualified from conferences, 68% attendee purchase influence (2024)\u003c\/li\u003e\n\u003cli\u003ecredibility: posters\/papers increase citations and trust\u003c\/li\u003e\n\u003cli\u003evisibility: speaking slots demonstrate outcomes\u003c\/li\u003e\n\u003cli\u003ecollaboration: networking → pilots\/partnerships (6–12 months)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eChannel-led model turns trials into contracts; FY24 \u003cstrong\u003e$1.03B\u003c\/strong\u003e, channel $639M\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAzenta (NASDAQ: AZTA) uses direct enterprise sales, digital portals, onsite demos and partner-led bundling to drive adoption across pharma, biotech and research centers; fiscal 2024 revenue was about $1.03B with ~$639M from channel-driven segments. MSAs, APIs and global field coverage reduce procurement friction and accelerate multi-site deployments, converting trials into long-term service contracts.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eChannel\u003c\/th\u003e\n\u003cth\u003eImpact\u003c\/th\u003e\n\u003cth\u003e2024 metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDirect sales\u003c\/td\u003e\n\u003ctd\u003eEnterprise deals\u003c\/td\u003e\n\u003ctd\u003e$1.03B rev\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePartners\u003c\/td\u003e\n\u003ctd\u003eBundled sales\u003c\/td\u003e\n\u003ctd\u003e$639M channel rev\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomer Segments\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal pharma companies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGlobal pharma companies require compliant, scalable sample and genomic services with robust MSAs, SLAs and audit readiness to support complex regulatory demands; global pharma R\u0026amp;D investment exceeded $200 billion in 2024. Multi-program pipelines deliver predictable, multi-year volume, and seamless integration with LIMS\/ERP systems is critical for operational continuity and data integrity.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBiotech \u0026amp; emerging biopharma\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBiotech and emerging biopharma customers demand flexible, cost-effective capacity to scale rapidly and prioritize speed plus hands-on technical guidance; global biopharma R\u0026amp;D spending exceeded $200 billion in 2024, driving outsized demand for outsourced capacity. Project-based budgets favor modular pricing that can cut upfront costs and shift to OPEX, and partners often co-develop novel assays to accelerate go-to-market timelines.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcademic \u0026amp; non-profit research\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGrant-funded labs demand reliable outcomes and transparent pricing to meet tight budgets; in 2024 NIH funded roughly 50,000 grants, underscoring scale. Open data and publications drive tool selection and collaboration. Targeted education and hands-on support increase platform adoption. Robust compliance frameworks enable translational and clinical-stage research partnerships.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHospitals \u0026amp; clinical labs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eHospitals and clinical labs require strict chain-of-custody, PHI security, rapid turnaround (24–72 hr SLAs common), validated assays and end-to-end traceability, with seamless LIS\/LIMS integration and robust QA\/QC to meet accreditation and clinical needs. \u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eChain-of-custody\u003c\/li\u003e\n\u003cli\u003ePHI security\u003c\/li\u003e\n\u003cli\u003eValidated assays\u003c\/li\u003e\n\u003cli\u003eLIS\/LIMS interface\u003c\/li\u003e\n\u003cli\u003eQA\/QC\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCROs \u0026amp; CDMOs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eCROs and CDMOs require repeatable, scalable workflows and commonly deliver white-label or integrated services to sponsors, with coordination across multiple sponsors essential for trial continuity; 2024 industry reports indicate over 50% of biopharma R\u0026amp;D activity is outsourced. Predictable SLAs (often 95%+ on key milestones) underpin timelines and commercial contracts. Reliable throughput and traceability drive partner selection.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRepeatable, scalable workflows\u003c\/li\u003e\n\u003cli\u003eWhite-label \/ integrated delivery\u003c\/li\u003e\n\u003cli\u003eCross-sponsor coordination\u003c\/li\u003e\n\u003cli\u003ePredictable SLAs (95%+ milestone adherence)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eScale-compliant MSAs\/SLAs and LIMS for \u003cstrong\u003e$200B+\u003c\/strong\u003e pharma, \u003cstrong\u003e\u0026gt;50%\u003c\/strong\u003e outsourced biotech, NIH \u0026amp; clinical labs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGlobal pharma (\u0026gt; $200B R\u0026amp;D 2024) needs compliant, scalable MSAs\/SLAs and LIMS integration for multi-year volumes. Biotech demand (rapid scale, OPEX models) surged with \u0026gt;50% R\u0026amp;D outsourcing in 2024. NIH-funded labs (~50,000 grants 2024) and clinical labs (24–72 hr SLAs, strict PHI\/chain-of-custody) require transparent pricing and validated assays.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSegment\u003c\/th\u003e\n\u003cth\u003e2024 metric\u003c\/th\u003e\n\u003cth\u003eTop need\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eGlobal pharma\u003c\/td\u003e\n\u003ctd\u003e$200B+ R\u0026amp;D\u003c\/td\u003e\n\u003ctd\u003eMSA\/SLA, LIMS\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBiotech\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;50% outsourced\u003c\/td\u003e\n\u003ctd\u003eFlexible capacity\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNIH labs\u003c\/td\u003e\n\u003ctd\u003e~50,000 grants\u003c\/td\u003e\n\u003ctd\u003eCost transparency\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClinical labs\u003c\/td\u003e\n\u003ctd\u003e24–72 hr SLA\u003c\/td\u003e\n\u003ctd\u003ePHI\/traceability\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eost Structure\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCapex for labs \u0026amp; automation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eInvestment in freezers (ultra-low units $10k–$25k in 2024), robotics ($25k–$500k) and sequencers (from ~$100k to ~$1M+) plus facilities is substantial for Azenta. Depreciation (commonly straight-line over 5–7 years) meaningfully compresses margins. Redundancy, validation and regular calibration increase operating cost and service readiness. Expansion is managed via phased capex planning over 3–5 year horizons.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSkilled labor \u0026amp; training\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eScientists, engineers and QA staff drive a large share of Azenta’s operating costs, with recruitment in tight biotech markets often taking ~60 days and costing roughly 20–30% of annual salary; continuous training keeps regulatory certifications current and consumes ongoing budget and ~5–10% of staff time; 24\/7 shift coverage adds shift differentials up to ~20%, materially raising labor spend.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConsumables \u0026amp; reagents\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNGS kits, lab plastics and chemicals drive Azenta’s variable costs, with NGS kit costs typically ranging $50–200 per sample and plastics often under $5 per sample.\u003c\/p\u003e\n\u003cp\u003eLong‑term vendor agreements and framework pricing are used to manage pricing volatility and secure supply.\u003c\/p\u003e\n\u003cp\u003eTight inventory controls target 30–90 days of stock to prevent stockouts, while QC and traceability protocols add procedural overhead and dedicated testing costs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLogistics \u0026amp; utilities\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eCold-chain shipping, refrigerated storage and high energy use are material to Azenta, with temperature-controlled logistics typically raising transport and storage costs by about 20–50% versus ambient handling; backup generators and continuous monitoring (IoT sensors) raise CAPEX\/OPEX but cut spoilage and downtime. Insurance and compliance for biologics add ongoing overhead, while route optimization and consolidation can reduce waste and fuel costs.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCold-chain premium: +20–50% cost\u003c\/li\u003e\n\u003cli\u003eBackup power \u0026amp; monitoring: higher CAPEX, lower downtime\u003c\/li\u003e\n\u003cli\u003eInsurance\/compliance: recurring overhead\u003c\/li\u003e\n\u003cli\u003eRoute optimization: lowers waste\/fuel\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSoftware, security \u0026amp; compliance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eCloud, LIMS\/ELN and analytics platforms drive recurring SaaS and consumption fees—global public cloud spend topped about $600 billion in 2023 and continued strong growth into 2024, raising Azenta’s platform hosting costs.\u003c\/p\u003e\n\u003cp\u003eCybersecurity and data privacy programs are mandatory, with enterprises allocating roughly 7–10% of IT spend to security in 2024; audits and ISO\/GxP certifications incur ongoing audit, consultant and remediation costs.\u003c\/p\u003e\n\u003cp\u003eIntegration and API maintenance require sustained engineering resources and third-party middleware subscriptions, creating persistent OpEx pressure and periodic upgrade projects.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCloud fees: global public cloud ~600B+ (2023) continuing into 2024\u003c\/li\u003e\n\u003cli\u003eSecurity spend: ~7–10% of IT budget (2024)\u003c\/li\u003e\n\u003cli\u003eAudits\/certifications: recurring audit and consultancy costs\u003c\/li\u003e\n\u003cli\u003eAPI\/integration: ongoing engineering and middleware fees\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh capex and labor-driven OpEx; \u003cstrong\u003e5–7y\u003c\/strong\u003e depreciation compresses margins\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eHigh capex (freezers $10k–$25k; sequencers $100k–$1M+; robotics $25k–$500k) with 5–7y depreciation and phased 3–5y rollouts compress margins. Labor drives OpEx; hiring ≈20–30% of salary and 24\/7 premiums ≈20%. Variable costs: NGS kits $50–$200\/sample; cold-chain +20–50% logistics.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eItem\u003c\/th\u003e\n\u003cth\u003e2024 Range\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eFreezers\u003c\/td\u003e\n\u003ctd\u003e$10k–$25k\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSequencers\u003c\/td\u003e\n\u003ctd\u003e$100k–$1M+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNGS kit\/sample\u003c\/td\u003e\n\u003ctd\u003e$50–$200\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCold‑chain premium\u003c\/td\u003e\n\u003ctd\u003e+20–50%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eR\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eevenue Streams\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGenomic services fees\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGenomic services fees are structured as per-sample or per-project pricing for sequencing and assays, with premiums charged for expedited turnaround and optional add-ons for QC and custom methods. Volume tiers deliver negotiated discounts as sample counts scale, and contract pricing often bundles routine QC to secure recurring revenue. Pricing flexibility supports both academic orders and larger biopharma programs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStorage \u0026amp; biorepository subscriptions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAzenta’s storage and biorepository subscriptions charge monthly or annual per-sample fees by temperature tier (industry ranges: $2–$25\/month per sample across ambient to -80°C), plus per-service fees for retrieval, aliquoting and shipping (commonly $20–$200 per request, shipping $100–$500). Premiums for redundancy and 24\/7 monitoring can add 10–30% to base fees. Long-term contracts (1–5 years) provide predictable recurring revenue and cash-flow stability.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAutomation systems \u0026amp; hardware\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eRevenues come from system sales plus installation and validation services, which typically add 10–15% on top of unit price. Optional modules increase ASP by roughly 15–30%, while maintenance and calibration plans generate recurring revenue equal to about 10–25% of initial system value annually. Paid upgrades extend system lifecycle by 2–4 years, boosting lifetime value and aftermarket margins.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSoftware \u0026amp; data analytics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAzenta monetizes Software \u0026amp; data analytics through SaaS licenses for sample management portals and per-report fees for bioinformatics pipelines and clinical-grade analytics.\u003c\/p\u003e\n\u003cp\u003eAPI access and tiered data storage charge by usage and retention while enterprise support packages and integration services drive uplift in ARR as of 2024.\u003c\/p\u003e\n\u003cp class=\"lst_crct\"\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSaaS licenses\u003c\/li\u003e\n\u003cli\u003ePipeline\/report fees\u003c\/li\u003e\n\u003cli\u003eAPI + storage tiers\u003c\/li\u003e\n\u003cli\u003eEnterprise support uplifts ARR\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProfessional \u0026amp; managed services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eProfessional and managed services drive recurring revenue through project management, method development, and consulting, plus onsite staffing and FTE-based engagements tied to long-term programs.\u003c\/p\u003e\n\u003cp\u003eCustom integrations and compliance support capture higher-margin work while formal change orders document and monetize evolving scope.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eProject management\u003c\/li\u003e\n\u003cli\u003eMethod development\u003c\/li\u003e\n\u003cli\u003eOnsite FTEs\u003c\/li\u003e\n\u003cli\u003eCustom integrations\u003c\/li\u003e\n\u003cli\u003eChange-order monetization\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePer-sample genomics fees; storage $2–$25\/mo; sequencing add-ons +15–30%\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAzenta earns per-sample\/genomics fees with volume tiers and expedited premiums; 2024 sequencing add-ons raise ASP ~15–30%.\u003c\/p\u003e\n\u003cp\u003eBiorepository subscriptions charge $2–$25\/month per sample by temperature; retrieval $20–$200 and shipping $100–$500 in 2024; long-term contracts 1–5 years.\u003c\/p\u003e\n\u003cp\u003eSaaS, API and analytics drive ARR via licenses, tiered storage and enterprise support (uplift ~15% ARR); maintenance 10–25% of system value annually.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eStream\u003c\/th\u003e\n\u003cth\u003e2024 metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eStorage\u003c\/td\u003e\n\u003ctd\u003e$2–$25\/mo per sample\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRetrieval\/Ship\u003c\/td\u003e\n\u003ctd\u003e$20–$200 \/ $100–$500\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMaintenance\u003c\/td\u003e\n\u003ctd\u003e10–25% annual\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"PESTEL Analysis","offers":[{"title":"Default Title","offer_id":58097900978524,"sku":"azenta-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0938\/8127\/0620\/files\/azenta-business-model-canvas.png?v=1781789062","url":"https:\/\/pestel-analysis.com\/products\/azenta-business-model-canvas","provider":"PESTEL ANALYSIS","version":"1.0","type":"link"}